176 related articles for article (PubMed ID: 30027406)
21. Permixon®, hexane-extracted Serenoa repens, inhibits human prostate and bladder smooth muscle contraction and exerts growth-related functions in human prostate stromal cells.
Tamalunas A; Wendt A; Springer F; Vigodski V; Ciotkowska A; Rutz B; Wang R; Huang R; Liu Y; Schulz H; Ledderose S; Kolben T; Magistro G; Stief CG; Hennenberg M
Life Sci; 2022 Nov; 308():120931. PubMed ID: 36084760
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation.
Descazeaud A; Weinbreck N; Robert G; Vacherot F; Abbou CC; Labrousse F; Allory Y; Rubin MA; de la Taille A
BJU Int; 2011 Jul; 108(2 Pt 2):E23-8. PubMed ID: 20840324
[TBL] [Abstract][Full Text] [Related]
24. The Role of Combination Therapy with α-Blockers and Hexanic Extract of
De Nunzio C; Salonia A; Gacci M; Ficarra V
J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498751
[TBL] [Abstract][Full Text] [Related]
25. [Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms].
Amdii RE; Al' Shukri AS
Urologiia; 2018 May; (2):114-120. PubMed ID: 29901305
[TBL] [Abstract][Full Text] [Related]
26. The lipidosterolic extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a comparison of two dosage regimens.
Giannakopoulos X; Baltogiannis D; Giannakis D; Tasos A; Sofikitis N; Charalabopoulos K; Evangelou A
Adv Ther; 2002; 19(6):285-96. PubMed ID: 12665049
[TBL] [Abstract][Full Text] [Related]
27. The combination of Serenoa repens, selenium and lycopene is more effective than serenoa repens alone to prevent hormone dependent prostatic growth.
Altavilla D; Bitto A; Polito F; Irrera N; Marini H; Arena S; Favilla V; Squadrito F; Morgia G; Minutoli L
J Urol; 2011 Oct; 186(4):1524-9. PubMed ID: 21855911
[TBL] [Abstract][Full Text] [Related]
28. 15 years' survey of safety and efficacy of Serenoa repens extract in benign prostatic hyperplasia patients with risk of progression.
Vinarov AZ; Spivak LG; Platonova DV; Rapoport LM; Korolev DO
Urologia; 2019 Feb; 86(1):17-22. PubMed ID: 29741118
[TBL] [Abstract][Full Text] [Related]
29. Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS Study.
Torkko KC; Wilson RS; Smith EE; Kusek JW; van Bokhoven A; Lucia MS
J Urol; 2015 Aug; 194(2):454-61. PubMed ID: 25828974
[TBL] [Abstract][Full Text] [Related]
30. Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study.
Stamatiou K; Pierris N
Arch Ital Urol Androl; 2013 Dec; 85(4):190-6. PubMed ID: 24399120
[TBL] [Abstract][Full Text] [Related]
31. Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
Magri V; Trinchieri A; Montanari E; Del Nero A; Mangiarotti B; Zirpoli P; de Eguileor M; Marras E; Ceriani I; Vral A; Perletti G
Arch Ital Urol Androl; 2007 Jun; 79(2):84-92. PubMed ID: 17695414
[TBL] [Abstract][Full Text] [Related]
32. Effects of Difaprost® on voiding dysfunction, histology and inflammation markers in patients with benign prostatic hyperplasia who are candidates for surgical treatment.
Suardi N; Gandaglia G; Nini A; Montorsi F; Pellucchi F; Agostini A; Rigatti P
Minerva Urol Nefrol; 2014 Jun; 66(2):119-25. PubMed ID: 24988203
[TBL] [Abstract][Full Text] [Related]
33. Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients.
Cai T; Tiscione D; Gallelli L; Verze P; Palmieri A; Mirone V; Bartoletti R; Malossini G
Arch Ital Urol Androl; 2016 Oct; 88(3):177-182. PubMed ID: 27711089
[TBL] [Abstract][Full Text] [Related]
34. Crocus sativus, Serenoa repens and Pinus massoniana extracts modulate inflammatory response in isolated rat prostate challenged with LPS.
Chiavaroli A; Recinella L; Ferrante C; Locatelli M; Carradori S; Macchione N; Zengin G; Leporini L; Leone S; Martinotti S; Brunetti L; Vacca M; Menghini L; Orlando G
J Biol Regul Homeost Agents; 2017 Jul-Sep,; 31(3):531-541. PubMed ID: 28889734
[TBL] [Abstract][Full Text] [Related]
35. Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis.
Orr C; Najm A; Biniecka M; McGarry T; Ng CT; Young F; Fearon U; Veale DJ
Arthritis Rheumatol; 2017 Nov; 69(11):2114-2123. PubMed ID: 28732135
[TBL] [Abstract][Full Text] [Related]
36. [Prediction of the effectiveness of the therapy of LUTS/BPH by Serenoa repens extracts].
Sivkov AV; Golovanov SA; Zhukova LV
Urologiia; 2019 Jul; (3):14-22. PubMed ID: 31356008
[TBL] [Abstract][Full Text] [Related]
37. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.
Plosker GL; Brogden RN
Drugs Aging; 1996 Nov; 9(5):379-95. PubMed ID: 8922564
[TBL] [Abstract][Full Text] [Related]
38. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
Ebelt K; Babaryka G; Figel AM; Pohla H; Buchner A; Stief CG; Eisenmenger W; Kirchner T; Schendel DJ; Noessner E
Prostate; 2008 Jan; 68(1):1-10. PubMed ID: 17948280
[TBL] [Abstract][Full Text] [Related]
39. Influence of immune inflammation on androgen receptor expression in benign prostatic hyperplasia tissue.
Wu ZL; Yuan Y; Geng H; Xia SJ
Asian J Androl; 2012 Mar; 14(2):316-9. PubMed ID: 22157983
[TBL] [Abstract][Full Text] [Related]
40. Serenoa repens in benign prostatic hypertrophy: analysis of 2 Italian studies.
Mantovani F
Minerva Urol Nefrol; 2010 Dec; 62(4):335-40. PubMed ID: 20944533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
